Denitsa Milanova

Chief Executive Officer at Medici Therapeutics.

Raised on Medici Therapeutics filings

$14.8M

of $14.8M offered across 1 Form D filing

Company

Biotech · Boston, MA

Tumor-infiltrating lymphocyte cell therapy for cancer

Tumor-infiltrating lymphocyte cell therapy for cancer

Medici Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Dec 4, 2025	Equity	$14.8M/ $14.8M	Form D

Also named on Medici Therapeutics filings